HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Posterior amorphous corneal dystrophy in a patient with 12q21.33 deletion.

Abstract
Posterior amorphous corneal dystrophy (PACD) (OMIM 612868) is a rare autosomal dominant disorder characterized by partial or complete posterior lamellar corneal opacification, decreased corneal thickness and flattening of the corneal curvature. PACD is associated with heterozygous deletions in chromosome band 12q21.33 harboring DCN, KERA, LUM, and EPYC which encode small leucine-rich proteoglycans. We report on a 7-year-old male patient with PACD who had an interstitial deletion of 1.3 Mb in 12q21.33. His mother carried a balanced insertional translocation involving this 12q21.33 segment which was inserted into the proximal part of the long arm of one chromosome 13. The patient corroborates previous observations that PACD is a contiguous gene syndrome caused by combined haploinsufficiency of DCN, KERA, LUM, and EPYC and provides the first example of a balanced chromosome rearrangement involving 12q21.33 in an unaffected parent.
AuthorsJanine Lenk, Joseph Porrmann, Martin Smitka, Ines Eger, Evelin Schröck, Karl Hackmann, Robert Herber, Frederik Raiskup, Andreas Tzschach
JournalOphthalmic genetics (Ophthalmic Genet) Vol. 39 Issue 5 Pg. 645-647 (10 2018) ISSN: 1744-5094 [Electronic] England
PMID30058938 (Publication Type: Case Reports, Journal Article)
Chemical References
  • DCN protein, human
  • Decorin
  • EPYC protein, human
  • KERA protein, human
  • LUM protein, human
  • Lumican
  • Proteoglycans
  • Small Leucine-Rich Proteoglycans
Topics
  • Child
  • Chromosome Deletion
  • Chromosomes, Human, Pair 12
  • Corneal Dystrophies, Hereditary (genetics, pathology)
  • Decorin (genetics)
  • Haploinsufficiency
  • Humans
  • Lumican (genetics)
  • Male
  • Prognosis
  • Proteoglycans (genetics)
  • Small Leucine-Rich Proteoglycans (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: